Bath & Body Works, Inc. (BBWI) Earnings Call Transcripts

Bath & Body Works, Inc.'s Latest Earnings Call - Q1 FY2027

In the first quarter of fiscal year 2026, Bath & Body Works reported net sales of $1.4 billion, a decline of 3.2% year-over-year, but slightly ahead of expectations. Adjusted earnings per share (EPS) was $0.32, also above guidance. Management reaffirmed their full-year guidance for net sales to decline between 4.5% and 2.5% and adjusted EPS between $2.40 and $2.65, indicating a cautious outlook amid ongoing pressures in the body care category. The company is focused on executing its consumer-first formula to drive future growth, with expectations for improvements in the second half of the year.

Reported metrics

Guidance from management

Management reaffirmed their full-year guidance for net sales to decline between 4.5% and 2.5% and adjusted EPS between $2.40 and $2.65, indicating a cautious outlook for the remainder of the year.

What management said

Yes, Lorraine, and I'll just add 1 thing, Daniel, if I could, right? We're in the early stages of this transformation. And as we provided our guidance 3 months ago and reaffirm that today, we believe we've planned the business prudently in line with our current trends. And as you think about the innovation, we're also being very surgical how we approach that and the impact so we can build on the things that win in th...

Sure. Thanks for the question, right? Overall, as you think about tariffs inclusive of the supply chain information that I spoke about, think about it as roughly neutral year-over-year with then an added headwind impact related to the crude oil pressures that we've seen, and we fill into our guidance that those continue. As you think about tariffs in particular, Q2 and fall, right, they're at lower rates than Q1, but...

What analysts pressed on

Analysts expressed concerns regarding the significant decline in body care sales and whether the company's transformation strategy would yield results in a timely manner. There were questions about the potential need to push out revenue inflection timelines into early 2027, reflecting skepticism about the pace of recovery.

Main topics on the call

• Body Care Performance — Body care sales declined mid-teens, primarily due to a shift towards accessories in the Disney collaboration and a pullback in everyday luxury assortments. Management stated, "We recognized that very quickly, and we've a...
• Product Innovation — Management emphasized the importance of product innovation, particularly in the body care segment, stating, "We are expecting stronger, more relevant innovation to begin showing up in the back half." This is part of thei...
• International Growth — International net sales increased by 5%, with retail sales up double digits. Management noted that international markets represent a "compelling opportunity with a long runway for high-return asset-light franchise growth...
• Guidance Reaffirmation — Management reaffirmed their full-year guidance for net sales to decline between 4.5% and 2.5% and adjusted EPS between $2.40 and $2.65, reflecting a cautious but steady outlook amid ongoing challenges.

Read the full Bath & Body Works, Inc. transcript (Q1 FY2027) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 40 Bath & Body Works, Inc. earnings call transcripts on record, spanning January 9, 2020 to May 27, 2026. Based on this history, Bath & Body Works, Inc. reports quarterly. The most recent call on file is dated May 27, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

BBWI

Exchange

NYSE

Country

US

Sector

Consumer Discretionary

Industry

Specialty Retail

Calls on record

40

First call

January 9, 2020

Most recent

May 27, 2026

Reporting cadence

quarterly